US Patent Issued to Ripple Therapeutics on Nov. 18 for "Crystalline forms of dexamethasone dimers and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,326, issued on Nov. 18, was assigned to Ripple Therapeutics Corp. (Toronto).

"Crystalline forms of dexamethasone dimers and uses thereof" was invented by Ian Charles Parrag (Mississauga, Canada), Matthew Alexander John Statham (Milton, Canada), Emma-Louise Elizabeth Moore (Mississauga, Canada), Bahareh Khalili (Mississauga, Canada), Judith Anne Williams (Toronto), Elizabeth Poloz (Kitchener, Canada) and Boris Gorin (Oakville, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure features polymorphs of a prodrug dimer of dexamethasone linked at the 21-C and 21'-C carbons via a carbonate-triethylene glycol-carbonate linker. Also disclos...